Quick Answer
AETHLON MEDICAL INC reported Diluted EPS of $8.58 per share (loss) for fiscal year 2025.
AETHLON MEDICAL INC Diluted EPS — Annual History
| Fiscal Year | Diluted EPS | YoY Change |
|---|---|---|
| 2025 | -$8.58 | +77.9% |
| 2024 | -$38.87 | -563.3% |
| 2023 | -$5.86 | -725.4% |
| 2022 | -$0.71 | — |
Quarterly Diluted EPS
| Quarter Ending | Diluted EPS | YoY | QoQ |
|---|---|---|---|
| December 31, 2025 | -$2.45 | +75.6% | +34.5% |
| September 30, 2025 | -$3.74 | +76.8% | -340.0% |
| June 30, 2025 | -$0.85 | +69.2% | +91.5% |
| December 31, 2024 | -$10.05 | -633.6% | +37.6% |
| September 30, 2024 | -$16.11 | -1220.5% | -483.7% |
| June 30, 2024 | -$2.76 | -104.4% | -101.5% |
| December 31, 2023 | -$1.37 | -10.5% | -12.3% |
| September 30, 2023 | -$1.22 | +33.7% | +9.6% |
- AETHLON MEDICAL INC showed an increase of +77.9% in Diluted EPS compared to the prior fiscal year.
- Over the 2022–2025 period, AETHLON MEDICAL INC’s diluted eps has declined by 1108.5% (from $0.71 per share (loss) to $8.58 per share (loss)).
- The most recent figure is from AETHLON MEDICAL INC’s fiscal year 2024 report (Form 10-K), filed with the SEC on June 26, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: